Biomerica, Inc. (BMRA)
NASDAQ: BMRA · IEX Real-Time Price · USD
0.665
-0.015 (-2.18%)
At close: Apr 26, 2024, 4:00 PM
0.690
+0.025 (3.73%)
After-hours: Apr 26, 2024, 4:50 PM EDT

Biomerica Revenue

Biomerica had revenue of $5.41M in the twelve months ending February 29, 2024, down -43.29% year-over-year. Revenue in the quarter ending February 29, 2024 was $1.02M, a -8.46% decrease year-over-year. In the fiscal year ending May 31, 2023, Biomerica had annual revenue of $5.34M, a decrease of -71.71%.

Revenue (ttm)
$5.41M
Revenue Growth
-43.29%
P/S Ratio
2.07
Revenue / Employee
$87,181
Employees
62
Market Cap
11.19M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 20235.34M-13.53M-71.71%
May 31, 202218.87M11.67M162.13%
May 31, 20217.20M506.32K7.57%
May 31, 20206.69M1.49M28.69%
May 31, 20195.20M-363.50K-6.53%
May 31, 20185.56M-227.49K-3.93%
May 31, 20175.79M651.85K12.68%
May 31, 20165.14M177.44K3.58%
May 31, 20154.96M-158.08K-3.09%
May 31, 20145.12M-1.35M-20.89%
May 31, 20136.47M391.83K6.44%
May 31, 20126.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 751.10M
Cosmos Health 49.59M
Biotricity 11.63M
iCoreConnect 8.15M
Elevai Labs 1.71M
Can-Fite BioPharma 743.00K
Inhibikase Therapeutics 260.50K
China SXT Pharmaceuticals 29.92K
Revenue Rankings